Microtubule-associated protein 1B light chain (MAP1B-LC1) negatively regulates the activity of tumor suppressor p53 in neuroblastoma cells

FEBS Lett. 2008 Aug 20;582(19):2826-32. doi: 10.1016/j.febslet.2008.07.021. Epub 2008 Jul 24.

Abstract

The tumor suppressor and transcription factor p53 is a key modulator of cellular stress responses and can trigger apoptosis in many cell types, including neurons. In this study, we have shown that the Microtubule-Associated Protein 1B (MAP1B) light chain can interact with the tumor suppressor p53. We also demonstrate that both p53 and the MAP1B light chain (MAP1B-LC1) alter their localization from the cytoplasm to the nucleus when neuroblastoma cells, SH-SY5Y, are treated with doxorubicin. Additionally, we demonstrate that the MAP1B-LC1 negatively regulates p53-dependent transcriptional activity of a reporter construct driven by the p21 promoter. Consequently, MAP1B-LC1 binds to p53 and this interaction leads to the inhibition of doxorubicin-induced apoptosis in SH-SY5Y cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / pharmacology*
  • Apoptosis*
  • Cell Line, Tumor
  • Cell Nucleus / metabolism
  • Cytoplasm / metabolism
  • Doxorubicin / pharmacology*
  • Genes, Reporter
  • Humans
  • Luciferases / genetics
  • Microtubule-Associated Proteins / metabolism*
  • Neuroblastoma / genetics
  • Neuroblastoma / metabolism*
  • Protein Structure, Tertiary
  • Protein Transport
  • Transcription, Genetic
  • Transcriptional Activation
  • Tumor Suppressor Protein p53 / antagonists & inhibitors
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / metabolism*

Substances

  • Antibiotics, Antineoplastic
  • MAP1B protein, human
  • Microtubule-Associated Proteins
  • Tumor Suppressor Protein p53
  • Doxorubicin
  • Luciferases